S. 4885

S. 4885: A bill to require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue produ

Introduced Gary Peters (D) SENATE_BILL — 119th Congress
Plain English Summary

S. 4885 is a bill that aims to direct the Secretary of Health and Human Services to launch a national education campaign. This campaign will focus on informing the public and healthcare providers about the potential risks and benefits associated with human cell and tissue products. The goal is to enhance awareness and understanding of these medical products.

Positive Media Summary

Supporters of S. 4885 have praised the bill for its proactive approach to public health education. They believe that increasing awareness about human cell and tissue products can lead to better-informed decisions by both patients and healthcare providers, ultimately improving health outcomes. The campaign is seen as a necessary step in addressing misinformation and promoting safe practices.

Negative Media Summary

Critics of S. 4885 have raised concerns about the potential for government overreach in health education. Some argue that the campaign may lead to unnecessary fear or confusion among the public regarding human cell and tissue products. Additionally, there are worries about the funding and resources that may be allocated to this campaign, questioning its effectiveness and necessity.

Conflict of Interest Analysis Deep Analysis
0/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The analysis of the campaign finance data reveals no direct industry overlaps between the subject matter of Bill S. 4885 and the top donor industries of Senator Gary Peters. This indicates that the financial interests of his donors do not intersect with the proposed legislation aimed at increasing awareness regarding human cell and tissue products. Since the bill focuses on education and awareness without specific industry ties, the potential for conflicts of interest appears minimal. Voters can be reassured that the motivations behind this bill are likely aligned with public health interests rather than donor influences.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
ORBIA FLUOR ENERGY MATERIALS (KOURA) BALLARD PARTNERS $120,000
TUNGSTEN MINING NL SQUIRE PATTON BOGGS $120,000
DELTA CAPITOL TAX PARTNERS, LLP $70,000
LEARN ALLIANCE (INFORMAL COALITION) CAPITOL TAX PARTNERS, LLP $40,000
FRAYM CASSIDY & ASSOCIATES, INC. $40,000
SCIOTO PROPERTIES LLC SQUIRE PATTON BOGGS $30,000
SUPPLY ENERGETICS, INC. CORNERSTONE GOVERNMENT AFFAIRS, INC. $30,000
VIEGA LLC SQUIRE PATTON BOGGS $30,000
GLOBAL TECHNICAL SYSTEMS GLOBAL TECHNICAL SYSTEMS $30,000
OISHII BALLARD PARTNERS $20,000
DIRECT KINETIC SOLUTIONS AMERICAN CAPITOL GROUP $15,000
SOCIETY OF GYNECOLOGIC ONCOLOGY CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. $10,000
CORNELL UNIVERSITY CAPITOL TAX PARTNERS, LLP undisclosed
CARL ZEISS AG FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) undisclosed
ZIPPO MANUFACTURING COMPANY SQUIRE PATTON BOGGS undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Gary Peters, ranked by total contributions.

Health Professionals $960,000,000
Individuals: $960,000,000 PACs: $0
Retired $300,000,000
Individuals: $300,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us